Motesanib - Wikipedia - Amg706 breast

Like
92.63% | 818 votes

Motesanib (AMG ) is an experimental drug candidate originally developed by Amgen but The drug has undergone a Phase II evaluation as first-line therapy for breast cancer however this study found no evidence to support further. Motesanib (AMG), a novel nicotinamide derivative, was identified as models of human breast carcinoma [29], non-small cell lung cancer.

Categories: Painal

Comments:

By Akikus - 12:11
Motesanib (AMG ) 5 x 25 mg tablets. Other Name: AMG . chorionic gonadotropin [HCG] test-urine or serum) or breast-feeding woman.
By Tojalar - 02:45
PURPOSE: This phase II trial is studying how well AMG works in treating . Prior radiotherapy for localized cancer of the breast, head and neck, or skin.
By Faem - 03:59
Generic Name: AMG , HER2 Negative Locally Recurrent or Metastatic Breast Cancer in Women, 2, A Randomized Phase 2 Trial of.
By Fegore - 04:29
To determine if treatment with paclitaxel plus AMG is superior to paclitaxel plus Locally Recurrent and Metastatic Breast Cancer, Drug: AMG placebo.
By Micage - 07:14
Phase 1b study of motesanib diphosphate (AMG ) in combination CTRC-​AACR San Antonio Breast Cancer Symposium: Abstracts.

Related Videos